A PHASE 1 HEALTHY VOLUNTEER DOSE ESCALATION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF INTRAVENOUS HUMAN IGG1 FC-F241A (NVG-2089) FOR THE TREATMENT OF ITP
EHA Library, Greg Coffey,
4159661
PROSPECTIVE, OPEN-LABEL, PHASE I/III STUDY OF THE PHARMACOKINETICS, EFFICACY AND SAFETY OF A FIBRINOGEN CONCENTRATE FROM HUMAN PLASMA, FOR THE TREATMENT AND PROPHYLAXIS OF BLEEDING IN PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY
EHA Library, Heike Boehm,
4159667
STUDY DESIGN OF PHASE 3 PART IN A PHASE 2/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SOVLEPLENIB IN WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA (ESLIM-02)
EHA Library, Bing Han,
4159673
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF ACUTE MYELOID LEUKEMIA IN CHILDREN FROM 1990 TO 2021: A TEMPORAL TREND ANALYSIS BASED ON THE GLOBAL BURDEN OF DISEASE STUDY 2021
EHA Library, Xiaoli Chen,
4159709